BioShares Biotechnology Price Prediction

BioShares Biotechnology Clinical Trials -- USA Etf  

USD 30.6  0.66  2.11%

Macroaxis is not in business of monitoring BioShares Biotechnology headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with BioShares Biotechnology Clinical Trials brand which may create opportunities for some arbitrage if properly timed. With BioShares Biotechnology hype-based prediction module you can estimate the value of BioShares Biotechnology Clinical Trials from the prospective of BioShares Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BioShares Biotechnology over a specific investment horizon. Check also BioShares Biotechnology Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

BioShares Biotechnology Estimiated After-Hype Price Volatility

 Next price density 
 
Expected price to next headline
January 20, 2018
30.6
Current Value
Downside upside
31.37
After-hype Price
Target Price Odds
 Above  Below  
36.62
Upside
Upside upside
BioShares Biotechnology is not too volatile asset. Analysis and calculation of next after-hype price of BioShares Biotechnology is based on 1 month time horizon.

BioShares Biotechnology Hype Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.67% 1.8% 0.11%  0.21% 1 Events / Month1 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
30.631.370.35%
1,125% 

BioShares Biotechnology Hype Timeline

On 20 of January BioShares Biotechnology Clinical Trials is traded for 30.6. This company has historical hype elasticity of 0.11 and average elasticity to hype of competition of 0.21. BioShares Biotechnology Clinical Trials is estimated to increase in value after the next headline with price going to jump to 31.37. The average volatility of media hype impact on the company stock price is about 1125.0%. The price escalation on the next news is estimated to be 0.35% where as daily expected return is currently at 0.67%. The volatility of related hype on BioShares Biotechnology is about 571.43% with expected price after next announcement by competition of 30.81. Considering 30-days investment horizon, the next estimated press release will be very soon.
Check also BioShares Biotechnology Basic Forecasting Models to cross-verify your projections.

BioShares Biotechnology Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Expected
Short fall
Potential
Upside
Value
At Risk
Maximum
Drawdown
Health Care Select Sector SPDR ETF 0.01 1 per month 0.00  0.0065 (0.55)  1.12 (0.36)  1.49 
iShares Nasdaq Biotechnology(0.12) 1 per month 0.42  0.0037 (0.72)  1.88 (1.23)  3.74 
Vanguard Health Care ETF 0.08 1 per month 0.00  0.0074 (0.54)  1.24 (0.48)  1.72 
SPDR SP Biotech ETF 0.8 1 per month 1.33  0.1 (1.23)  2.56 (1.99)  5.86 
iShares US Healthcare 0.28 1 per month 0.00  0.0026 (0.54)  1.13 (0.48)  1.62 
iShares Global Healthcare 0.84 1 per month 0.00 (0.13) (0.51)  1.04 (0.45)  1.48